Organ Transplant Rejection: Immune Mechanisms and Prevention Strategies
Transplant rejection occurs when the recipient’s immune system recognizes the donor organ as foreign.
Key Mechanisms
- Acute rejection (days–months): Host T cells recognize donor MHC (HLA) mismatches → direct/indirect allorecognition → cytotoxic attack, cytokine storm.
- Hyperacute rejection (minutes–hours): Pre-existing anti-donor antibodies (ABO or HLA) → complement activation → immediate graft thrombosis.
- Chronic rejection (months–years): Antibody-mediated vascular remodeling (transplant vasculopathy), fibrosis, gradual function loss.
- Antibody-mediated rejection (AMR): Donor-specific antibodies (DSA) → endothelial injury, C4d deposition.
- Ischemia-reperfusion injury: Procurement/storage damage → inflammation → upregulates immunogenicity.
Prevention & Management
- HLA matching (best for kidney).
- Induction immunosuppression (thymoglobulin, basiliximab).
- Maintenance: calcineurin inhibitor + antimetabolite + steroid (tailored).
- Monitoring: protocol biopsies, DSA surveillance, gene expression profiling.
- Treatment of rejection: pulse steroids, T-cell depletion, plasmapheresis/IVIG for AMR.
Despite advances, rejection remains the major barrier to long-term graft survival.
Kidney Disease - Related Articles
- Understanding Kidney Dialysis: A Comprehensive Guide
- How to Manage Fatigue When Living with Chronic Kidney Disease
- Supporting Students with Chronic Kidney Failure: Educational Strategies & Resources
- Azathioprine and Kidney Damage: Risks & Prevention
- Renal Artery Stenosis and Peripheral Artery Disease: Symptoms, Causes, and Diagnosis
- Understanding Interstitial Fibrosis in Kidney Disease
- Understanding Renal Failure: Causes, Symptoms & Risk Factors
